Correspondence to editorial on "Sorafenib vs. Lenva-tinib in advanced hepatocellular carcinoma after at-ezolizumab/bevacizumab failure: A real-world study"

Chon, Young Eun; Kim, Dong Yun; Chon, Hong Jae; Kim, Do Young

doi:10.3350/cmh.2024.0394

YUHSpace

BROWSE

87 147

Cited 0 times in

Correspondence to editorial on "Sorafenib vs. Lenva-tinib in advanced hepatocellular carcinoma after at-ezolizumab/bevacizumab failure: A real-world study"

Authors: Chon, Young Eun ; Kim, Dong Yun ; Chon, Hong Jae ; Kim, Do Young

Citation: CLINICAL AND MOLECULAR HEPATOLOGY, Vol.30(4) : 1005-1008, 2024-10

Journal Title: CLINICAL AND MOLECULAR HEPATOLOGY

ISSN: 2287-2728

Issue Date: 2024-10

Keywords: Hepatocellular carcinoma ; Immune check point inhibitor ; Atezolizumab and bevacizumab failure ; Salvage therapy

Abstract: [No abstract available]

DOI: 10.3350/cmh.2024.0394

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Kim, Do Young(김도영)
Kim, Dong Yun(김동윤) https://orcid.org/0000-0002-2471-3385

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/202325

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Correspondence to editorial on "Sorafenib vs. Lenva-tinib in advanced hepatocellular carcinoma after at-ezolizumab/bevacizumab failure: A real-world study"

YUHSpace

BROWSE

Browse

Links